MedTrace Logo

Screening Protocol

NCT06135727 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2025-09-10

No results posted yet for this study

Summary

The objective of this study is to collect data for the development and validation a screening process using aggregate data.

In this study, data collection will encompass both retrospective and prospective approaches across multiple sites in the United States.

Conditions

Interventions

DEVICE

Maestro2 OCT

3D Wide (12mmx9mm) OCT scan using the Maestro (Topcon, Japan)

Sponsors & Collaborators

  • Topcon Corporation

    lead INDUSTRY

Principal Investigators

  • Mary Durbin, PhD · Topcon Corporation

  • Nevin W. El-Nimri, OD, PhD · Topcon Corporation

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-07
Primary Completion
2024-08-02
Completion
2024-08-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06135727 on ClinicalTrials.gov